
Ep178: Peyton Greenside on ML-Guided Biologics Discovery
The Long Run with Luke Timmerman
00:00
Revolutionizing Drug Discovery with AI
This chapter explores the innovative use of AI and cell-free technology in biologics drug discovery, highlighting the transformative speed and efficiency of rapid feedback mechanisms. It underscores the shift from traditional methods to the ability to produce and analyze thousands of unique antibody designs in mere days, revolutionizing therapeutic design.
Transcript
Play full episode